Biomarker Market
Biomarker Market - Global Industry Assessment & Forecast
#
Pages:
210
Base Year:
2023
Oct - 2024
Format:
Report Code:
VMR-2682
Segments Covered
By
Types Safety Biomarkers, Efficacy Biomarkers, Predictive Biomarkers, Surrogate Biomarkers, Pharmacodynamic Biomarkers, Prognostics Biomarkers, Validation Biomarkers
-
By
Applications Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, Others
-
By
Product Consumable, Services, Software
-
By
Disease Cancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases, Others
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD XX Million |
 Revenue 2032:
|
USD XX Million |
 Revenue CAGR
(2024 - 2032): |
XX |
Fastest Growing Region (2024 -
2032)
|
XX |
Largest Region (2023):
|
XX |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Biomarker Market Segment Analysis
- Biomarker Types Outlook (Revenue, USD Million, 2018 - 2030)
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- Biomarker Applications Outlook (Revenue, USD Million, 2018 - 2030)
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- Biomarker Product Outlook (Revenue, USD Million, 2018 - 2030)
- Consumable
- Services
- Software
- Biomarker Disease Outlook (Revenue, USD Million, 2018 - 2030)
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
-
North America Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
-
North America Biomarker Market, by Product
- Consumable
- Services
- Software
-
North America Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- U.S.
- U.S. Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- U.S. Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- U.S. Biomarker Market, by Product
- Consumable
- Services
- Software
- U.S. Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- U.S. Biomarker Market, by Types
- Canada
- Canada Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- Canada Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- Canada Biomarker Market, by Product
- Consumable
- Services
- Software
- Canada Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- Canada Biomarker Market, by Types
-
Mexico
- Mexico Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- Mexico Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- Mexico Biomarker Market, by Product
- Consumable
- Services
- Software
- Mexico Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- Mexico Biomarker Market, by Types
-
North America Biomarker Market, by Types
- Europe
-
Europe Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
-
Europe Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
-
Europe Biomarker Market, by Product
- Consumable
- Services
- Software
-
Europe Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- U. K.
- U.K. Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- U.K. Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- U.K. Biomarker Market, by Product
- Consumable
- Services
- Software
- U.K. Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- U.K. Biomarker Market, by Types
- France
- France Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- France Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- France Biomarker Market, by Product
- Consumable
- Services
- Software
- France Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- France Biomarker Market, by Types
-
Germany
- Germany Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- Germany Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- Germany Biomarker Market, by Product
- Consumable
- Services
- Software
- Germany Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- Germany Biomarker Market, by Types
-
Italy
- Italy Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- Italy Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- Italy Biomarker Market, by Product
- Consumable
- Services
- Software
- Italy Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- Italy Biomarker Market, by Types
-
Spain
- Spain Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- Spain Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- Spain Biomarker Market, by Product
- Consumable
- Services
- Software
- Spain Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- Spain Biomarker Market, by Types
-
Rest of Europe
- Rest of Europe Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- Rest of Europe Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- Rest of Europe Biomarker Market, by Product
- Consumable
- Services
- Software
- Rest of Europe Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- Rest of Europe Biomarker Market, by Types
-
Europe Biomarker Market, by Types
- Asia Pacific
-
Asia Pacific Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
-
Asia Pacific Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
-
Asia Pacific Biomarker Market, by Product
- Consumable
- Services
- Software
-
Asia Pacific Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- China
- China Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- China Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- China Biomarker Market, by Product
- Consumable
- Services
- Software
- China Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- China Biomarker Market, by Types
- Japan
- Japan Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- Japan Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- Japan Biomarker Market, by Product
- Consumable
- Services
- Software
- Japan Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- Japan Biomarker Market, by Types
-
Germany
- Germany Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- Germany Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- Germany Biomarker Market, by Product
- Consumable
- Services
- Software
- Germany Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- Germany Biomarker Market, by Types
-
India
- India Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- India Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- India Biomarker Market, by Product
- Consumable
- Services
- Software
- India Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- India Biomarker Market, by Types
-
South Korea
- South Korea Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- South Korea Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- South Korea Biomarker Market, by Product
- Consumable
- Services
- Software
- South Korea Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- South Korea Biomarker Market, by Types
-
South East Asia
- South East Asia Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- South East Asia Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- South East Asia Biomarker Market, by Product
- Consumable
- Services
- Software
- South East Asia Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- South East Asia Biomarker Market, by Types
-
Rest of Asia Pacific
- Rest of Asia Pacific Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- Rest of Asia Pacific Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- Rest of Asia Pacific Biomarker Market, by Product
- Consumable
- Services
- Software
- Rest of Asia Pacific Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- Rest of Asia Pacific Biomarker Market, by Types
-
Asia Pacific Biomarker Market, by Types
- Latin America
-
Latin America Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
-
Latin America Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
-
Latin America Biomarker Market, by Product
- Consumable
- Services
- Software
-
Latin America Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- Brazil
- Brazil Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- Brazil Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- Brazil Biomarker Market, by Product
- Consumable
- Services
- Software
- Brazil Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- Brazil Biomarker Market, by Types
- Argentina
- Argentina Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- Argentina Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- Argentina Biomarker Market, by Product
- Consumable
- Services
- Software
- Argentina Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- Argentina Biomarker Market, by Types
-
Rest of Latin America
- Rest of Latin America Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- Rest of Latin America Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- Rest of Latin America Biomarker Market, by Product
- Consumable
- Services
- Software
- Rest of Latin America Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- Rest of Latin America Biomarker Market, by Types
-
Latin America Biomarker Market, by Types
- Middle East & Africa
-
Middle East & Africa Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
-
Middle East & Africa Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
-
Middle East & Africa Biomarker Market, by Product
- Consumable
- Services
- Software
-
Middle East & Africa Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- GCC Countries
- GCC Countries Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- GCC Countries Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- GCC Countries Biomarker Market, by Product
- Consumable
- Services
- Software
- GCC Countries Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- GCC Countries Biomarker Market, by Types
- South Africa
- South Africa Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- South Africa Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- South Africa Biomarker Market, by Product
- Consumable
- Services
- Software
- South Africa Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- South Africa Biomarker Market, by Types
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Biomarker Market, by Types
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- Rest of Middle East & Africa Biomarker Market, by Applications
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- Rest of Middle East & Africa Biomarker Market, by Product
- Consumable
- Services
- Software
- Rest of Middle East & Africa Biomarker Market, by Disease
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- Rest of Middle East & Africa Biomarker Market, by Types
-
Middle East & Africa Biomarker Market, by Types
- North America
FAQ
Frequently Asked Question
What is the global demand for Biomarker in terms of revenue?
-
The global Biomarker valued at USD XX Million in 2023 and is expected to reach USD XX Million in 2032 growing at a CAGR of XX.
Which are the prominent players in the market?
-
The prominent players in the market are F. Hoffmann-La Roche AG, Epigenomics AG, Abbott, Thermo Fisher Scientific Inc, General Electric, Eurofins Scientific, Johnson & Johnson Services, Inc., QIAGEN, Bio-Rad Laboratories, Inc., Siemens Healthineers AG, Merck KGaA, PerkinElmer Inc., Agilent Technologies, Inc..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of XX between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Biomarker include
Which region accounted for the largest share in the market?
-
XX was the leading regional segment of the Biomarker in 2023.
